PMID: 8938564Nov 1, 1996Paper

Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
R W ByhardtE C Borden


Fifteen patients with stage II, IIIA, and IIIB non-small cell lung cancer (NSCLC) received subcutaneous (s.c.) recombinant, glycosylated, human interferon-beta 1a (Rebif; rHuIFN-beta 1a) on each day of conventionally fractionated radiation therapy (RT) given in 2.0 Gy fractions to 60 Gy in 6 weeks. The rHuIFN-beta 1a was generated in CHO cells by recombinant DNA technology and is identical to natural IFN-beta produced by fibroblasts in primary sequence and glycosylation. Cohorts of three patients each were treated with escalating doses of rHuIFN-beta 1a: 1.5, 3, 6, 12, and 24 MIU/m2 per treatment day. Acute toxicity was assessed according to modified WHO criteria; late toxicity was graded using RTOG late toxicity criteria. The maximum tolerated dose (MTD) of rHuIFN-beta 1a was defined as the dose level immediately below that in which dose-limiting toxicity occurred in > or = two of six patients. Immunomodulatory effects and antigenicity of rHuIFN-beta 1a were assessed by 2-5A synthetase, beta 2-microglobulin, and neopterin levels and by measurement of anti-rHuIFN-beta antibodies, respectively. Fourteen of fifteen patients experienced grades 1-3 acute (early) toxicity (< or = 90 days), which was primarily gastrointestinal: dysph...Continue Reading


May 1, 1975·Chest·A L Goldman, R Enquist
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P MaasiltaK Mattson
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D E HallahanR R Weichselbaum
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·C A PerezR Birch
Aug 1, 1987·International Journal of Radiation Oncology, Biology, Physics·L R HolstiK Cantell
Dec 1, 1988·Journal of Interferon Research·A M LiberatiG Peretti
Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·R W ByhardtU Almagro
Jan 1, 1985·Journal of Interferon Research·J A MerrittL A Ball
Jan 1, 1984·Journal of Interferon Research·M N GouldE C Borden
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Oct 20, 1993·International Journal of Radiation Oncology, Biology, Physics·S McDonaldA Muhs

❮ Previous
Next ❯


Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·H SchmidbergerC F Hess
Dec 1, 2006·Veterinary and Comparative Oncology·D H Thamm
Oct 19, 2005·Pharmacology & Therapeutics·Adil Javed, Anthony T Reder
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brigette B Y MaLillian L Siu
Jun 30, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J BundH J Habermalz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.